Smart Money Alert

Trident Lifeline Limited

DecreasedQuarterly

543616PharmaceuticalsMarket Cap₹449 Cr

Stake

4.82% → 2.63%

Nav Capital

Foreign Investor

The move

Nav Capital decreased its stake in Trident Lifeline Limited from 4.82% to 2.63%, selling 261,000 shares for ₹6.87 Cr in a rights issue.

About Trident Lifeline Limited

Visit stock

A pharmaceutical manufacturer incorporated in 2014, Trident Lifeline produces and distributes a comprehensive range of pharmaceutical products across India's healthcare sector. The company operates in the generics segment, focusing on formulations for various therapeutic areas and medical conditions. Its operations span manufacturing facilities, quality control protocols, and distribution networks designed to serve healthcare providers, hospitals, and patients nationwide through established channels.

About Nav Capital

Visit investor

Nav Capital is an India-focused investment platform whose Nav Capital VCC Emerging Star Fund is among the most active foreign portfolio investors anchoring Indian SME IPOs. It pursues high-conviction investing across private and public markets.

Get the next move the moment it happens.

Follow Nav Capital and Trident Lifeline Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Trident Lifeline Limited shareholders Nav Capital's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Trident Lifeline Limited

Nav Capital

Direction, size, price and stake change for this move, with what it means for the company.

15 Sept 2026. Sign in to see this move

Craft Emerging Markets

Direction, size, price and stake change for this move, with what it means for the company.